Lv41
798 积分 2022-08-30 加入
Early Real‐World Implementation of Once‐Weekly Insulin Icodec in Type 2 Diabetes
6小时前
已完结
Vascular Effects of Insulin and Their Relation to Endothelial Dysfunction, Insulin Resistance and Hypertension
22天前
已完结
A review of survodutide: a new dual acting agonist
1个月前
已关闭
IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective
4个月前
已完结
IcoSema and the evolution of fixed-ratio insulin–GLP-1 receptor agonist therapies
4个月前
已完结
Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis
5个月前
已完结
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
5个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
5个月前
已完结
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
5个月前
已完结
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease
5个月前
已完结
皖公网安备34019202002308
